If people from India are thinking about low-cost and safe medicines of all kinds, Mankind Pharma often comes to the forefront. In the past 30 years Mankind Pharma has earned a reputation that is built on the principles of high-quality affordable and accessibility. In the present, Mankind Pharma is one of the most renowned Pharmaceutical firms in India that is constantly expanding its reach not just on a local scale, but also in the global market. If you’re looking to learn more about the net worth of mankind pharmaceutical the CEOs, owners, and Market capitalization, then this article will provide all the information you’ll need to know.
The Company’s Overview
Mankind Pharma began with a small team and a huge vision in the year 1995. Since then, it has grown to become the fourth largest drug firm in India. The company creates pharmaceuticals, manufactures and sells them for chronic and acute conditions and also well-known consumer health products.
| Category | Information |
| Name of the Company | Mankind Pharma Ltd. |
| It was founded | 1995 |
| Headquarters | India |
| Industry | Pharmaceuticals & Consumer Healthcare |
| The Founders | Ramesh Juneja & Rajeev Juneja |
| CEO | Sheetal Arora |
| Market Presence | 34+ countries |
| Products | 1000+ approved products |
Popular brands like Manforce, Prega News, and Gas-O-Fast have contributed to Mankind Pharma achieve good visibility with consumers in India.
Who is the owner of Mankind Pharma?
Brothers Ramesh Juneja and Rajeev Juneja co-founded Mankind Pharma and remain the primary owners. They and the Juneja family trusts control an overwhelming share of Mankind Pharma. Their long-term perspective and disciplined management has played an important influence on the company’s development.
In 2025, Ramesh’s estimated net worth is around Rs27,472 crore. Rajeev Juneja’s net worth stands approximately Rs26,613.5 crore, indicating their accomplishment in establishing one of the most lucrative Pharma companies in India.
What Leads Mankind Pharma?
Mankind Pharma has experienced leadership. Ramesh Juneja is the Chairman of the chair, and Rajeev Juneja is Vice Chairman and the Managing Director. Sheetal Arora is the CEO currently in charge of the day-to-day operations and execution of strategy. Together, the leadership team will focus on innovation, in-house manufacturing and extensive distribution, focusing on the most remote areas of India.
Net Value as well as Market Capitalization
Mankind Pharma made its IPO to the public market in April 2023. It is listed with both the NSE along with the BSE. Market capitalization for Mankind Pharma as on mid December 2025 ranges from Rs88000 crore and the range of Rs91000 crore. This is a sign of the faith of investors in the company due to the steady growth in revenue and the company’s dominance within the Indian pharmaceutical industry.
Why Mankind Pharma Stands Out
Mankind Pharma is unique because Mankind Pharma is a company that sticks to its promise of not leaving any citizen in the dust. Mankind Pharma is a company that combines the affordability of its products with quality that is uncompromising and ensures that medications are readily available via their extensive supply chain. With over 34 countries and over 29 years of excellence in pharmaceuticals, Mankind Pharma remains committed to maintaining its position in the ranks of most trusted healthcare providers across India.